OverviewSuggest Edit

dMed is a biopharmaceutical company that facilitates the globalization of innovative drugs, accelerates the development of medicines and improves clinical development capabilities. Its research organization provides advisory services on the basis of a clinical development plan, regulatory strategy, approval processes, and clinical trial support. This enables biopharmaceutical and medical companies to improve clinical trial efficiency and thereby increase the probability of their products' success.


dMed is headquartered in

Location Map

Latest Updates

Employees (est.) (Feb 2020)137(+4%)

dMed Office Locations

dMed has an office in
Show all (1)

dMed Financials and Metrics

Summary Metrics

Founding Date


dMed total Funding

$58 m

dMed latest funding size

$50 m

Time since last funding

4 months ago

dMed investors

dMed's latest funding round in October 2019 was reported to be $50 m. In total, dMed has raised $58 m
Show all financial metrics

dMed Online and Social Media Presence

Embed Graph

dMed Frequently Asked Questions

  • When was dMed founded?

    dMed was founded in 2016.

  • How many employees does dMed have?

    dMed has 137 employees.

  • Who are dMed competitors?

    Competitors of dMed include Alentis Therapeutics, Faes Farma and VenatoRx Pharmaceuticals.

  • Where are dMed offices?

    dMed has an office in.

  • How many offices does dMed have?

    dMed has 1 office.